Marlins Closer Pete Fairbanks Diagnosed With TOS
Pete Fairbanks will undergo surgery for thoracic outlet syndrome, sidelining him for nearly a year.
Updated on Sept. 19, 2026 in Baseball
Live Poll
Do you believe long-term, high-value player contracts represent a sound investment for your local team?
The Miami Marlins announced that relief pitcher Pete Fairbanks has been diagnosed with thoracic outlet syndrome. Fairbanks, who faced persistent nerve issues throughout the season, will undergo surgery performed by Dr. Gregory J. Pearl.
Why it matters
The diagnosis addresses the root cause of the nerve irritation that plagued the pitcher throughout his 2026 campaign. His extended recovery timeline significantly alters the Marlins' bullpen outlook for the upcoming season.
Fairbanks logged a 6.31 ERA over 46 outings during the 2026 season, recording 19 saves in 23 opportunities. The standard recovery period for this surgical procedure is approximately nine to 10 months.
The players
Pete Fairbanks
He is a veteran relief pitcher who signed a one-year, $13 million contract with the Miami Marlins.
Dr. Gregory J. Pearl
He is a medical specialist designated to perform the procedure to treat compression of nerves and blood vessels in the thoracic outlet.
Miami Marlins
The professional baseball team holds the contract of the relief pitcher and confirmed the diagnosis following his medical evaluation.
The details
The decision for surgery follows a season marked by recurring right median nerve irritation that forced Fairbanks to exit games early on three separate occasions. He reported a sharp sensation in his right brachial plexus during his final appearance in Arizona before receiving the diagnosis.
Timeline
Fairbanks experienced nerve issues while with the Rays in 2024.
Fairbanks recorded 46 appearances for the Marlins in the 2026 season.
Fairbanks exited his final game in Arizona on September 14, 2026.
The Marlins officially announced the diagnosis on September 18, 2026.
The Big Picture
This surgery follows a established pattern set by the standard clinical recovery protocol for thoracic outlet syndrome, which consistently necessitates a multi-month rehabilitation window for professional athletes. The outcome highlights the broader challenge teams face when managing high-leverage bullpen arms suffering from recurring neurovascular compression.
The Marlins will face a significant vacancy in their high-leverage rotation for the start of the next season following the loss of a closer who accounted for 19 saves. Fantasy managers and team officials must now account for a bullpen depth chart that loses a primary late-inning option for the majority of the upcoming year.
The takeaway
Thoracic outlet syndrome remains a complex hurdle for professional pitchers that often requires long-term surgical intervention. Early detection and definitive treatment are the primary methods for extending the careers of athletes facing these recurring nerve-related setbacks.
Further reading
For more news on the league's roster shifts, check out the latest Baseball updates.
Live Poll
Do you believe long-term, high-value player contracts represent a sound investment for your local team?
